[1]
Kwon, D.H. et al. 2021. Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway. EXCLI Journal. 20, (May 2021), 968–982. DOI:https://doi.org/10.17179/excli2021-3506.